Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 184

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 184
---
 in the Merger Agreement, to receive the Merger Consideration. |

| • |     | As of the Effective Time, each holder of shares of Enfusion Common Stock converted into the right to receive the                                                                                                                                         
 Merger Consideration pursuant to the Merger Agreement will cease to have any rights with respect thereto, except the right to receive the Merger Consideration and cash in lieu of fractional shares of Clearwater Common Stock in accordance with the   
 Merger Agreement. As of the LLC Merger Effective Time, each holder of Enfusion Common Units converted into the right to receive the Merger Consideration pursuant to the Merger Agreement will cease to have any rights with respect thereto, except the 
 right to receive the Merger Consideration and cash in lieu of fractional shares of Clearwater Common Stock in accordance with the Merger Agreement.                                                                                                      |

| • |     | Each share of Enfusion Class B Common Stock that is issued and outstanding immediately prior to the                                       
 Effective Time will be automatically canceled and will cease to exist and no consideration will be delivered in exchange for such shares. |

| • |     | Each share of Enfusion Common Stock and Enfusion Class B Common Stock held in the treasury of Enfusion and                                                                                                                                         
 any shares of Enfusion Common Stock and Enfusion Class B Common Stock owned by Clearwater, Merger Sub or Merger Sub II immediately prior to the Effective Time will automatically be canceled and will cease to exist and no consideration will be 
 delivered in exchange for such shares.                                                                                                                                                                                                             |

| • |     | Each share of common stock of Merger Sub issued and outstanding immediately prior to the Effective Time will                                                                                                                                            
 automatically be converted into and become one fully paid, nonassessable share of common stock, par value $0.001 per share, of the Surviving Corporation and will constitute the only outstanding shares of capital stock of the Surviving Corporation. |

| • |     | Each Enfusion Common Unit held in the treasury of Enfusion OpCo and any Enfusion Common Units owned by Enfusion,                                                                                                                                        
 Clearwater, Enfusion US 1, Inc., Enfusion US 2, Inc., Enfusion US 3, Inc. or any other subsidiary of Enfusion will remain outstanding, and any Enfusion Common Units owned by Acquirer, Merger Sub or Merger Sub II immediately prior to the Effective  
 Time will automatically be canceled and will cease to exist and no consideration will be delivered in exchange for such Enfusion Common Units, and each Enfusion Common Unit